Morphiceptin

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID7114
Ligand NameMorphiceptin
PubMed Compound Id119303
StructureProduct Image
Molecular FormulaC28H35N5O5
Molecular Weight521.6
SMILESC1C[C@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N4CCC[C@H]4C(=O)N
SynonymsMorphiceptin
Deproceptin
74135-04-9
Tyr-pro-phe-pro amide
beta-Casomorphine(1-4) amide
Tyr-Pro-Phe-Pro-NH2
NH(4)-Tyr-pro-phe-pro-conh(2)
H-Tyr-Pro-Phe-Pro-NH2
b-Casomorphin-4-amide
L-Tyrosyl-L-prolyl-L-phenylalanyl-L-prolinamide
UNII-97TZA8ANPC
97TZA8ANPC
(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide
L-Prolinamide, L-tyrosyl-L-prolyl-L-phenylalanyl-
beta-Casomorphin-4-NH2
beta-Casomorphin-4-amide
Tyr-pro-phe-delta-pro-NH2
Tyrosyl-prolyl-phenylalanyl-delta-prolinamide
(2S)-1-((2S)-2-((((2S)-1-((2S)-2-amino-3-(4-hydroxyphenyl)propanoyl)pyrrolidin-2-yl)(hydroxy)methylidene)amino)-3-phenylpropanoyl)pyrrolidine-2-carboximidate
(2S)-1-((2S)-2-amino-3-(4-hydroxyphenyl)propanoyl)-N-((2S)-1-((2S)-2-carbamoylpyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pyrrolidine-2-carboxamide
(2S)-1-[(2S)-2-({[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-3-phenylpropanoyl]pyrrolidine-2-carboximidate
Tyr-pro-phe-D-pro-NH2
Tyrosyl-prolyl-phenylalanyl-D-prolinamide
CHEMBL362991
beta-Casomorphin (1-4) amide (bovine) acetate salt
(S)-1-(L-tyrosyl)-N-((S)-1-((S)-2-carbamoylpyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pyrrolidine-2-carboxamide
[D-Pro4]morphiceptin
.beta.-Casomorphin-4-NH2
DTXSID10995574
CHEBI:177741
HY-P1701
BDBM50166066
AKOS040753135
NCGC00163202-01
DA-79178
FC108657
MS-29674
CS-0090884
NS00123295
G12217
Morphiceptin;H-Tyr-Pro-Phe-Pro-NH2 acetate salt
N-(1-{2-[Hydroxy(imino)methyl]pyrrolidin-1-yl}-1-oxo-3-phenylpropan-2-yl)-1-tyrosylpyrrolidine-2-carboximidic acid
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm